Phase IIa Trial of Trastuzumab Emtansine with Pertuzumab for Patients with Human Epidermal Growth Factor Receptor 2-positive, Locally Advanced, or Metastatic Breast Cancer

Reshma Mahtani; Kathy Miller; Véronique Diéras; Nadia Harbeck; Fabrice Andre; Luca Gianni; Kathy S. Albain; Diana Crivellar; Liang Fang; Glenn Michelson; Sanne L. de Haas; Howard Burris

Phase IIa Trial of Trastuzumab Emtansine with Pertuzumab for Patients with Human Epidermal Growth Factor Receptor 2-positive, Locally Advanced, or Metastatic Breast Cancer

Reshma Mahtani, Kathy Miller, Véronique Diéras, Nadia Harbeck, Fabrice Andre, Luca Gianni, Kathy S. Albain, Diana Crivellar, Liang Fang, Glenn Michelson, Sanne L. de Haas, Howard Burris

Miami Cancer Institute

Research output: Contribution to journal › Article › peer-review

Original language	American English
Journal	Journal of Clinical Oncology
Volume	21
State	Published - May 10 2014

Disciplines

Medicine and Health Sciences

Cite this

Mahtani, R., Miller, K., Diéras, V., Harbeck, N., Andre, F., Gianni, L., Albain, K. S., Crivellar, D., Fang, L., Michelson, G., de Haas, S. L., & Burris, H. (2014). Phase IIa Trial of Trastuzumab Emtansine with Pertuzumab for Patients with Human Epidermal Growth Factor Receptor 2-positive, Locally Advanced, or Metastatic Breast Cancer. Journal of Clinical Oncology, 21.

@article{3fd97db137c44859848d334930219267,

title = "Phase IIa Trial of Trastuzumab Emtansine with Pertuzumab for Patients with Human Epidermal Growth Factor Receptor 2-positive, Locally Advanced, or Metastatic Breast Cancer",

author = "Reshma Mahtani and Kathy Miller and V{\'e}ronique Di{\'e}ras and Nadia Harbeck and Fabrice Andre and Luca Gianni and Albain, {Kathy S.} and Diana Crivellar and Liang Fang and Glenn Michelson and {de Haas}, {Sanne L.} and Howard Burris",

note = "1 Kathy D. Miller, Indiana University Melvin and Bren Simon Cancer Center, Indianapolis, IN; Reshma L. Mahtani, Sylvester Comprehensive Cancer Center, Miami, FL; Kathy S. Albain, Loyola University Chicago Stritch School of Medicine, Maywood, IL; Liang Fang, Glenn Michelson, Genentech, South San Francisco, CA; Howard A.",

year = "2014",

month = may,

day = "10",

language = "American English",

volume = "21",

journal = "Journal of Clinical Oncology",

}

TY - JOUR

T1 - Phase IIa Trial of Trastuzumab Emtansine with Pertuzumab for Patients with Human Epidermal Growth Factor Receptor 2-positive, Locally Advanced, or Metastatic Breast Cancer

AU - Mahtani, Reshma

AU - Miller, Kathy

AU - Diéras, Véronique

AU - Harbeck, Nadia

AU - Andre, Fabrice

AU - Gianni, Luca

AU - Albain, Kathy S.

AU - Crivellar, Diana

AU - Fang, Liang

AU - Michelson, Glenn

AU - de Haas, Sanne L.

AU - Burris, Howard

N1 - 1 Kathy D. Miller, Indiana University Melvin and Bren Simon Cancer Center, Indianapolis, IN; Reshma L. Mahtani, Sylvester Comprehensive Cancer Center, Miami, FL; Kathy S. Albain, Loyola University Chicago Stritch School of Medicine, Maywood, IL; Liang Fang, Glenn Michelson, Genentech, South San Francisco, CA; Howard A.

PY - 2014/5/10

Y1 - 2014/5/10

UR - https://pubmed.ncbi.nlm.nih.gov/24733796/

M3 - Article

VL - 21

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

ER -

Phase IIa Trial of Trastuzumab Emtansine with Pertuzumab for Patients with Human Epidermal Growth Factor Receptor 2-positive, Locally Advanced, or Metastatic Breast Cancer

Disciplines

Other files and links

Cite this